Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Fineotex Chemical Ltd

FCL
NSE
22.98
0.22%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Fineotex Chemical Ltd

FCL
NSE
22.98
0.22%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2,676Cr
Close
Close Price
22.98
Industry
Industry
Speciality Chemicals
PE
Price To Earnings
25.82
PS
Price To Sales
4.63
Revenue
Revenue
578Cr
Rev Gr TTM
Revenue Growth TTM
2.07%
PAT Gr TTM
PAT Growth TTM
-15.22%
Peer Comparison
How does FCL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
FCL
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
138132145138153142146126120137138184
Growth YoY
Revenue Growth YoY%
13.4-2.68.226.811.17.30.3-9.1-21.7-3.4-5.545.9
Expenses
ExpensesCr
105101107981151071099299112107149
Operating Profit
Operating ProfitCr
333238403835363421253135
OPM
OPM%
23.823.826.329.125.024.825.027.217.818.422.519.0
Other Income
Other IncomeCr
244545758987
Interest Expense
Interest ExpenseCr
000010000000
Depreciation
DepreciationCr
111122232333
PBT
PBTCr
333440444038413626313538
Tax
TaxCr
78911108996698
PAT
PATCr
262632333029322820252630
Growth YoY
PAT Growth YoY%
52.928.751.746.517.211.71.8-15.5-34.0-14.2-18.78.2
NPM
NPM%
18.919.821.723.819.920.622.022.116.818.318.916.4
EPS
EPS
0.20.20.30.30.30.30.30.20.20.20.20.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
102110127141182196219368517569533578
Growth
Revenue Growth%
17.77.815.611.129.27.711.368.540.410.1-6.38.4
Expenses
ExpensesCr
858298111148162178297404421406466
Operating Profit
Operating ProfitCr
1628293034354171113148127112
OPM
OPM%
16.225.723.221.218.917.718.619.321.826.123.919.4
Other Income
Other IncomeCr
521051-111767172431
Interest Expense
Interest ExpenseCr
000111111111
Depreciation
DepreciationCr
1111111346911
PBT
PBTCr
2029383434225673115158141131
Tax
TaxCr
6991098111625373230
PAT
PATCr
152029242414455790121109101
Growth
PAT Growth%
86.738.743.6-17.61.5-41.2211.427.757.435.1-9.8-7.2
NPM
NPM%
14.318.422.917.013.37.320.415.417.321.320.517.5
EPS
EPS
1.10.10.30.20.20.10.40.50.81.10.90.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
222222222222222222222323
Reserves
ReservesCr
546990113137147187240327425708756
Current Liabilities
Current LiabilitiesCr
191820192931506864896778
Non Current Liabilities
Non Current LiabilitiesCr
0001111235912
Total Liabilities
Total LiabilitiesCr
101114140161195208267339423548815878
Current Assets
Current AssetsCr
45505972108115166232224286261313
Non Current Assets
Non Current AssetsCr
566581898692101108199262554564
Total Assets
Total AssetsCr
101114140161195208267339423548815878

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
141419612289131079769
Investing Cash Flow
Investing Cash FlowCr
-12-10-11-94-19-7-1-102-46-273
Financing Cash Flow
Financing Cash FlowCr
-3-1-6-4-3-4-4-6-6-24176
Net Cash Flow
Net Cash FlowCr
-3-1-1-3146-28126-27
Free Cash Flow
Free Cash FlowCr
812144422-15-988491
CFO To PAT
CFO To PAT%
93.467.365.826.549.4198.220.623.5119.880.263.5
CFO To EBITDA
CFO To EBITDA%
82.748.364.921.234.981.522.718.895.365.454.5

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2503633816514561657291,9952,5794,0812,632
Price To Earnings
Price To Earnings
19.620.714.728.620.312.717.136.229.234.024.3
Price To Sales
Price To Sales
2.53.33.04.62.50.83.35.45.07.24.9
Price To Book
Price To Book
3.34.03.44.82.91.03.57.67.49.13.6
EV To EBITDA
EV To EBITDA
14.612.712.521.612.94.317.227.522.427.320.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.142.141.339.535.537.335.736.134.438.738.6
OPM
OPM%
16.225.723.221.218.917.718.619.321.826.123.9
NPM
NPM%
14.318.422.917.013.37.320.415.417.321.320.5
ROCE
ROCE%
26.531.634.024.621.413.126.628.132.535.119.5
ROE
ROE%
19.122.225.817.715.38.421.321.725.727.114.9
ROA
ROA%
14.517.720.814.912.56.916.716.821.222.113.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Fineotex Chemical Limited (**FCL**) is a leading Indian multinational specialty performance chemical manufacturer. The company has evolved from a textile-centric player into a diversified global platform providing sustainable, technology-driven solutions across the entire value chain of the **Textile**, **Oil & Gas**, **Water Treatment**, and **Cleaning & Hygiene** industries. Operating as a **zero-debt** entity with a robust cash reserve of over **₹350 crore**, FCL focuses on high-entry-barrier specialty formulations rather than commodity products. The company manages a vast portfolio of over **1,600 SKUs** and **470+ product categories**, serving approximately **70 countries**. --- ### **Strategic Market Diversification & Product Verticals** FCL’s business model is built on "Green Chemistry," focusing on reducing utility costs (water, steam, energy) and environmental impact (BOD/COD levels) for its clients. | Segment | Key Solutions & Applications | Strategic Positioning | |:---|:---|:---| | **Textile Specialty** | Pre-treatment, Dyeing, Printing, and Finishing (Softeners, Silicones, Enzymes). | Focus on **Finishing** (**60%** of textile revenue); high customer stickiness due to technical switching risks. | | **Oil & Gas** | Demulsifiers, Corrosion inhibitors, Biocides, and advanced fluid additives. | Targeting the **$11.5 billion** North American market via the **CrudeChem** acquisition. | | **Cleaning & Hygiene** | Floor cleaners, hand-washes, and specialized housekeeping care. | Fungible capacities allow rapid shifts to serve brands like **Patanjali** and **Ghadi**. | | **Water Treatment** | **Diquest** brand polymers, scale inhibitors, and coagulants. | Addressing **Zero Liquid Discharge (ZLD)** mandates and industrial flow efficiency. | #### **Innovation Spotlight: AquaStrike Premium** FCL recently launched **AquaStrike Premium**, a next-generation biotechnology-based mosquito control solution formulated with **Azadirachtin**. * **Regulatory Status:** Approved by the **Central Insecticide Board (India)** and declared a **Non-Pesticide** in Malaysia. * **Safety:** Certified non-toxic by **NSF** even in drinkable water; it replaces traditional gaseous chemical spraying with a non-toxic liquid film. --- ### **Global Manufacturing Footprint & Capacity Expansion** FCL is aggressively scaling its infrastructure to meet a volume growth target that saw a **39% Y-o-Y** increase in **Q3 FY26**. Total global capacity is projected to reach **200,000 MTPA** by March 2026. | Facility Location | Capacity (MTPA) | Status / Strategic Role | |:---|:---|:---| | **Ambernath, India** | **119,000** | Primary hub; includes a new **15,000 MTPA** specialty unit and a **100kWp Solar Plant**. | | **Midland, Texas (USA)** | **68,000** | Commissioned **March 2026**; serves the Permian Basin energy region. | | **Mahape, India** | **36,500** | Modern infrastructure with **GMP** and **FDA** pharma approvals. | | **Selangor, Malaysia** | **6,500** | Operated by **Biotex**; the global hub for R&D and high-end raw materials. | --- ### **The North American Energy Pivot: CrudeChem Acquisition** A cornerstone of FCL’s growth strategy is the **December 2025** acquisition of a **53.33%** controlling stake in **CrudeChem Technologies (CCT)**. * **Objective:** Build a **$200 million** oilfield chemical business. * **Infrastructure:** A new **15-acre** facility in Midland, Texas, integrates blending, R&D, and logistics. * **Synergy:** Enables cross-selling of FCL’s sustainable chemistries into the L48 energy region, focusing on ESG-compliant oilfield solutions. --- ### **Research, Development & Sustainability Ecosystem** FCL operates as a "solution provider," leveraging a **NABL-accredited** laboratory and global partnerships to prevent product obsolescence. * **Strategic Alliances:** Collaborations with **EuroDye-CTC** (Belgium) for dyeing, **HealthGuard** (Australia) for anti-microbials, and the **Sasmira Institute** (India) for a state-of-the-art textile R&D center. * **Green Chemistry:** Approximately **44%** of revenue is derived from eco-friendly chemistries. * **Certifications:** **Bluesign®** partner, **ZDHC** contributor, **GOTS**, **ISO 14001**, and **EcoVadis** Commitment Badge. * **Customer Centricity:** Technical teams of **44+ experts** provide on-site troubleshooting, typically resolving complaints within **2 days**. --- ### **Financial Performance & Capital Structure** FCL maintains a disciplined, "net debt neutral" profile, funding expansion primarily through internal accruals and strategic equity raises. #### **Consolidated Financial Metrics** | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | |:---|:---|:---|:---| | **Total Income (₹ Cr)** | **557.64** | **585.51** | **517.00** | | **EBITDA Margin (%)** | **23.85%** | **26.08%** | **21.78%** | | **PAT (₹ Cr)** | **109.21** | **121.03** | **89.55** | | **ROCE (%)** | **~34%** | **34.35%** | **-** | #### **Capital Restructuring (Late 2025)** To improve market liquidity and reward shareholders, FCL executed: * **Stock Split:** Sub-division from face value **₹2** to **₹1**. * **Bonus Issue:** A **4:1** bonus allotment in October 2025. * **Fundraising:** Raised **₹342.55 crore** via preferential allotments to fund inorganic growth. * **Credit Rating:** Upgraded to **ICRA A+ (Positive)** and **ICRA A1+**. --- ### **Risk Management & Mitigation Framework** FCL employs an **Enterprise Risk Management Programme** to navigate the complexities of the specialty chemical sector. * **Raw Material Volatility:** Mitigated by a flexible pricing model that maintains **20-25% Operating Profit Margins** despite fluctuations in crude-linked intermediates. * **Geopolitical Risk:** Export share recently dipped to **19%** due to instability in **Bangladesh**; however, the company is diversifying via the **India-UK** and **India-EU FTAs**, which are expected to provide zero-duty access. * **Financial Risks:** * **Forex:** Managed through **natural hedging**. * **Credit:** No significant concentration risk due to a highly distributed customer base. * **Liquidity:** Strong cash position of **₹352 crore** ensures all expansion is well-capitalized. * **Regulatory Compliance:** Early adoption of **ZDHC** and **REACH** standards mitigates the risk of tightening environmental laws.